Page last updated: 2024-09-04

16-hydroxyandrost-4-en-3,17-dione and Diseases of Endocrine System

16-hydroxyandrost-4-en-3,17-dione has been researched along with Diseases of Endocrine System in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernhardt, R; Hartmann, MF; Khatri, Y; Milhim, M; Neunzig, J; Sánchez-Guijo, A; Schiffer, L; Wudy, SA; Zapp, J1

Other Studies

1 other study(ies) available for 16-hydroxyandrost-4-en-3,17-dione and Diseases of Endocrine System

ArticleYear
The steroid metabolite 16(β)-OH-androstenedione generated by CYP21A2 serves as a substrate for CYP19A1.
    The Journal of steroid biochemistry and molecular biology, 2017, Volume: 167

    Topics: Androgens; Androstenedione; Aromatase; Aromatase Inhibitors; Catalysis; Child, Preschool; Crystallography, X-Ray; Dose-Response Relationship, Drug; Endocrine System; Endocrine System Diseases; Escherichia coli; Estrogen Receptor alpha; Female; Humans; Kinetics; Magnetic Resonance Spectroscopy; Receptors, Androgen; Recombinant Proteins; Spectrophotometry, Ultraviolet; Steroid 21-Hydroxylase; Steroids

2017